Isu Abxis ranked among the top searched stocks for 7 days in the past month.


As of 2:31 PM on the 19th, Isu Abxis is trading at 10,700 KRW, down 6.14% from the previous day. This represents a 53.08% increase compared to February 4. Isu Abxis, an affiliate of the Isu Group, is known as a company that develops antibiotic treatments and provides medical services.

Today, foreigners have net sold 2,000 shares of Isu Abxis, and institutions have net sold 55,000 shares, according to provisional data. Over the past 5 days, individual investors have net bought 453,364 shares, while foreigners and institutions have net bought 398,725 shares and net sold 645,654 shares, respectively.


On February 10, Isu Abxis became a market issue with the news of "strong performance due to contract manufacturing of the Russian COVID-19 vaccine."





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an article automation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing